Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing women with post-menopausal bleeding.

Elisabeth Epstein1, Lil Valentin

  • 1Department of Obstetrics and Gynaecology, University of Lund, Malmö University Hospital, Malmö 205 02, Sweden. elisabeth.epstein@obst.mas.lu.se

Best Practice & Research. Clinical Obstetrics & Gynaecology
|May 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors associated with deep perineal wound dehiscence after second-degree perineal tears or episiotomy.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

ADNEX-AI: automated extraction of ultrasound predictors for interpretable ovarian cancer risk stratification.

NPJ precision oncology·2025
Same author

Head-to-head comparison of the RMI and ADNEX models to estimate the risk of ovarian malignancy: a systematic review and meta-analysis of external validation studies.

BMJ open·2025
Same author

External validation of ultrasound-based models for differentiating between benign and malignant adnexal masses: a nationwide prospective multicenter study (IOTA phase 6).

American journal of obstetrics and gynecology·2025
Same author

Patient satisfaction with ultrasound, whole-body CT and whole-body diffusion-weighted MRI for pre-operative ovarian cancer staging: a multicenter prospective cross-sectional survey.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

International multicenter validation of AI-driven ultrasound detection of ovarian cancer.

Nature medicine·2025

Transvaginal ultrasound reliably identifies low-risk post-menopausal bleeding (PMB) patients (<4mm endometrium) from high-risk (>5mm endometrium). Endometrial thickness measurement is key for assessing endometrial cancer risk.

Area of Science:

  • Gynecology
  • Diagnostic Imaging
  • Oncology

Background:

  • Post-menopausal bleeding (PMB) necessitates accurate risk stratification for endometrial pathology.
  • Transvaginal ultrasound (TVUS) is a primary tool for evaluating the endometrium in PMB.
  • Hormone replacement therapy (HRT) use can influence endometrial thickness, requiring consideration in interpretation.

Purpose of the Study:

  • To assess the utility of TVUS in differentiating low-risk from high-risk women with PMB based on endometrial thickness.
  • To evaluate the role of hydrosonography in detecting focal intrauterine lesions.
  • To determine appropriate management strategies for women with PMB based on ultrasound findings.

Main Methods:

  • Transvaginal ultrasound measurement of endometrial thickness.

Related Experiment Videos

  • Hydrosonography (saline infusion sonography) for enhanced visualization of the uterine cavity.
  • Correlation of ultrasound findings with pathological outcomes (implicitly, though not detailed in abstract).

    • Main Results:

    • An endometrial thickness of ≤4 mm reliably identifies low-risk women (cancer risk 0.1-1.0%), justifying withholding endometrial sampling.
    • An endometrial thickness of ≥5 mm is associated with focal intrauterine lesions in approximately 80% of cases.
    • Hydrosonography effectively rules out focal lesions; operative hysteroscopy is recommended for their removal.

    Conclusions:

    • TVUS measurement of endometrial thickness is a reliable method for estimating endometrial cancer risk in PMB.
    • Women with PMB and endometrial thickness ≤4 mm have a low risk of malignancy, but follow-up needs are undetermined.
    • Operative hysteroscopy is superior to D&C for removing focal lesions identified in high-risk PMB patients.